Exxonmobil Investment Management Inc. TX decreased its position in Waters Co. (NYSE:WAT) by 13.2% during the 4th quarter, Holdings Channel reports. The firm owned 12,646 shares of the medical instruments supplier’s stock after selling 1,931 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in Waters were worth $2,443,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Oppenheimer Asset Management Inc. grew its holdings in Waters by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after purchasing an additional 2 shares during the last quarter. ETF Managers Group LLC acquired a new stake in Waters in the second quarter valued at $106,000. Intellectus Partners LLC grew its holdings in Waters by 4.9% in the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after purchasing an additional 31 shares during the last quarter. Edmond DE Rothschild Holding S.A. acquired a new stake in Waters in the second quarter valued at $160,000. Finally, Acrospire Investment Management LLC grew its holdings in Waters by 117.4% in the second quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock valued at $170,000 after purchasing an additional 500 shares during the last quarter. 92.12% of the stock is currently owned by institutional investors.
In related news, Director Thomas P. Salice sold 3,500 shares of the stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $200.03, for a total transaction of $700,105.00. Following the transaction, the director now directly owns 20,349 shares in the company, valued at $4,070,410.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joann A. Reed sold 1,386 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $194.07, for a total value of $268,981.02. The disclosure for this sale can be found here. Insiders have sold 93,159 shares of company stock worth $18,412,172 over the last quarter. 5.07% of the stock is currently owned by company insiders.
Shares of Waters Co. (NYSE:WAT) opened at $209.75 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16. The company has a market capitalization of $16,680.00, a price-to-earnings ratio of 30.94, a P/E/G ratio of 2.81 and a beta of 0.82. Waters Co. has a 52 week low of $137.72 and a 52 week high of $210.08.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The business had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same quarter last year, the company earned $1.57 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. research analysts expect that Waters Co. will post 7.42 EPS for the current year.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.